A COMPARISON OF ANTI-TYPE 2 DIABETES MELLITUS DRUGS IN CANADA, THE UNITED STATES AND THE UNITED KINGDOM
dc.contributor.advisor | Tewodros, Eguale, MD, PhD (Research Advisor) Associate Professor of Pharmaceutical Economics and Policy | |
dc.contributor.author | MOHAMMED ABDULLAH ALQAHTANI | |
dc.date | 2016 | |
dc.date.accessioned | 2022-06-02T10:28:55Z | |
dc.date.available | 2022-06-02T10:28:55Z | |
dc.degree.department | PHARMACY | |
dc.identifier.other | 29793 | |
dc.identifier.uri | https://drepo.sdl.edu.sa/handle/20.500.14154/62871 | |
dc.publisher | Saudi Digital Library | |
dc.title | A COMPARISON OF ANTI-TYPE 2 DIABETES MELLITUS DRUGS IN CANADA, THE UNITED STATES AND THE UNITED KINGDOM | |
dc.type | Thesis | |
sdl.thesis.level | Master | |
sdl.thesis.source | SACM - United States of America |